Clinical
RSSArticles
-
Dextromethorphan-Quinidine Combo for Alzheimer’s Patients with Agitation
The combination of dextromethorphan and quinidine appears promising for management of aggression in Alzheimer’s patients.
-
Fixing Intractable Pruritus: Azathioprine
This retrospective study supports consideration of azathioprine when other efficacious treatments have been exhausted.
-
What's Holding Case Managers Back?
Reimbursement and regulatory barriers are slowing down the transformative change that technology makes possible.
-
Ultrasound for Dense Breasts — Is It Worth the Cost?
A cost-effectiveness model found that supplemental ultrasound screening after a negative mammogram for women with dense breasts substantially increases costs without yielding significant benefit.
-
Concomitant Hysteroscopic Sterilization and Endometrial Ablation: What Are the Risks?
In this retrospective cohort study, women who underwent concomitant hysteroscopic sterilization and endometrial ablation procedures were more likely to have inadequate 3-month hysterosalpingram testing to confirm tubal occlusion.
-
Are We on the Threshold of a New Approach to Evaluating Women with Recurrent Pregnancy Loss?
A small retrospective cohort study raises the possibility that advanced genetic techniques can be used to analyze the products of conception in women with recurrent pregnancy loss to identify those most likely to have treatable reasons for their miscarriages.
-
Induction of Labor in Patients with Previous Cesarean Sections
ABSTRACT & COMMENTARY: Great improvements have been made while the fear of litigation ebbs.
-
ECG Review: A 43-Year-Old Man with Atypical Chest Pain
-
Clinical Briefs
In this section: reversing the anticoagulant effect of dabigatran; considering the likelihood of occult cancer causing unprovoked deep venous thrombosis; and cardiovascular autonomic neuropathy occurs earlier in type 2 diabetes.
-
Evolocumab Injection (Repatha)
Evolocumab is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-C.